MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $705,000 | +72.0% | 11,695 | +31.2% | 0.01% | +66.7% |
| Q1 2016 | $410,000 | +113.5% | 8,915 | +123.9% | 0.00% | +200.0% |
| Q4 2015 | $192,000 | -46.4% | 3,982 | -52.7% | 0.00% | -66.7% |
| Q3 2015 | $358,000 | +3.8% | 8,417 | +178.6% | 0.00% | 0.0% |
| Q2 2015 | $345,000 | +13.5% | 3,021 | +28.4% | 0.00% | +50.0% |
| Q1 2015 | $304,000 | +31.0% | 2,352 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $232,000 | -12.8% | 2,326 | -13.4% | 0.00% | 0.0% |
| Q3 2014 | $266,000 | +25.5% | 2,687 | -2.4% | 0.00% | 0.0% |
| Q2 2014 | $212,000 | +1.4% | 2,754 | -15.0% | 0.00% | 0.0% |
| Q1 2014 | $209,000 | +16.8% | 3,241 | +15.5% | 0.00% | 0.0% |
| Q4 2013 | $179,000 | -68.5% | 2,807 | -70.4% | 0.00% | -60.0% |
| Q3 2013 | $568,000 | +126.3% | 9,482 | +86.2% | 0.01% | +150.0% |
| Q2 2013 | $251,000 | – | 5,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
| Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
| APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
| March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
| HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
| BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
| Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
| Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
| TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |